Well because there is a concrete date which will finalise a final step to approval, of course the share is worth more today as this uncertainly has been mitigated
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-39
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.05 |
Change
0.000(0.00%) |
Mkt cap ! $1.198B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1459 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 27668 | 7 |
View Market Depth
| Last trade - 10.04am 05/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
Day chart unavailable